DNI Gabbard Launches Investigation Into 120 US-Funded Foreign Biolabs Including 40 in Ukraine
Director of National Intelligence Tulsi Gabbard told the New York Post on Monday that her office is reviewing more than 120 US-funded biological laboratories across more than 30 countries pursuant to President Trump's executive order on
Gabbard's ODNI review consolidates oversight of a biolab network managed for decades through diffuse DoD and NIH channels with minimal accountability. The Ukraine subset carries the sharpest risk: 40-plus facilities near an active front with Russia having demonstrated prior intent to access them. CTR origins of many labs complicate the gain-of-function framing, since CTR was designed to neutralize threats rather than develop them, but ODNI's flagging of active clinical trials suggests scope drift. Reported through a single New York Post interview with no independent corroboration, the investigation may be primarily a retroactive audit validating 2022 Ukraine biolab claims the Biden administration denied. A public report within six months is uncertain, with classification of pathogen inventories creating structural barriers to disclosure.
3 sources
- DNI Tulsi Gabbard Investigating 120 Foreign Biolabs Funding by US Government -
The Last Refuge - DNI Tulsi Gabbard probes US funding to more than 120 biolabs abroad -
New York Post (via AOL) - DNI Gabbard confirms she is investigating more than 120 US-funded biolabs around the world, and specifically mentions 40 in UKRAINE -
Pravda USA